It has been reported that SNHG6 could function as a sponge for miR-101-3p in CCA35, 36, and miR-101-3p inhibits CCA angiogenesis through targeting vascular endothelial growth factor (VEGF)36. Here, VEGFA is linked to cholangiocarcinoma.